 Dr. Eric L. Ding (born 1983 in Shanghai) is an American nutritionist and epidemiologist, a faculty at Harvard School of Public Health, Executive Director of the Campaign for Cancer Prevention, Director of Epidemiology with Microclinic International, a WEF Global Shaper, and a Soros Fellow. Ding founded the Campaign for Cancer Prevention, currently with over 6 million members on Causes, to accelerate medical research. He was recognized in the New York Times and USA Today as a whistle-blower in the Vioxx drug safety controversy. He also writes as an op-ed contributor for The Huffington Post. Ding was born in Shanghai, China, and was raised in the United States. He is an alum of the Pennsylvania Governor's School for Health Care. As a child, doctors discovered that he had developed a baseball-size tumor in his chest. His initial prognosis was for less than 5 years life, but he survived. Ding attended The Johns Hopkins University, graduating with Honors in Public Health and Phi Beta Kappa. He earned his dual doctorate in epidemiology, doctorate in nutrition, and doctoral minor in biostatistics, from Harvard at age 23. He then completed his postdoctoral fellowship in Nutrition at the Harvard School of Public Health. At Harvard, he also received the Derek Bok Distinction in Teaching Award from Harvard College. He once attended Boston University School of Medicine, but did not receive a degree. Ding's research focuses on obesity and nutritional risk factors for diabetes, heart disease, and cancer - with focus on translational approaches for health communication, prevention, social networks on health, and social media technology for health. His expertise also includes evidence-based medicine, and global disease burden and policy. He has published major reports, including in the New England Journal of Medicine, Journal of the American Medical Association, PLoS Medicine, The Lancet, which together have received over 1900 citations. Ding is a Fellow of the Paul and Daisy Soros Foundation, and as chief corresponding author of a JAMA report, recognized for his role as a whistle-blower of the controversial drug safety of Vioxx and other COX-2 inhibitors, he was recognized and named in the New York Times and USA Today. He has also served as advisor for the World Health Organization and the EU European Commission, as judge for the annual VH1 Do Something Awards, and was an appointed member of the World Health Organization-sponsored Global Burden of Disease Project. His work has been cited by directors of CDC and CMMS in the framework of the federal "Million Hearts" Initiative. He has consulted for the WHO and the European Commission. He also serves as Director of Epidemiology of Microclinic International, as principal investigator of several intervention programs for obesity and diabetes prevention. Having survived a childhood battle with a baseball-sized tumor, Ding founded the Campaign for Cancer Prevention, and was featured in Newsweek, the New York Times, and on 40 million bags of Doritos, sponsored by Do Something. He is also known for developing a direct-to-science model for accelerating cancer research, and advocate of crowdfunding for medical research. To date, his efforts have raised over $500,000 in public donations for innovative cancer research, and directs several cancer prevention advocacy platforms totaling over 17 million members. A former keynote presenter at Google TechTalk, he been featured in Google Research for development of a 130-year cohort study of Major League Baseball to study obesity and mortality. Ding's work has been mentioned in books, including CauseWired by Tom Watson, and Zilch: The Power of Zero in Business by Nancy Lublin, and Shift & Reset: Strategies for Addressing Serious Issues in a Connected Society by Brian Reich. He was recognized by Craig Newmark as among “16 People and Organizations Changing the World in 2012”. He also received the 2012 Outstanding Young Leader Award from the Boston Chamber of Commerce. He formerly served on the Board of Advisors for Madonna's Raising Malawi Foundation. 
